MARKET

CTXR

CTXR

Citius Pharmaceuticals Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.790
+0.020
+1.13%
After Hours: 1.770 -0.02 -1.12% 19:56 03/05 EST
OPEN
1.780
PREV CLOSE
1.770
HIGH
1.790
LOW
1.470
VOLUME
18.34M
TURNOVER
--
52 WEEK HIGH
2.900
52 WEEK LOW
0.4150
MARKET CAP
225.16M
P/E (TTM)
-3.8256
1D
5D
1M
3M
1Y
5Y
Hot Reddit Penny Stocks For Your Watch List In March 2021
Mar 05, 2021 (Penny Stocks via COMTEX) -- Reddit Penny Stocks Continue Surging But Are They Worth The Risk? The stock market continues selling off today and...
Penny Stocks · 2d ago
Citius Pharmaceuticals to Feature Product Candidates Including Stem-Cell Therapy for COVID-19-Related Acute Respiratory Conditions at H.C. Wainwright Global Life Sciences Conference March 9-10
, /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will present at the H.C. Wainwright Global Li...
PR Newswire - PRF · 3d ago
H.C. Wainwright Reiterates a Buy Rating on Citius Pharmaceuticals (CTXR)
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Citius Pharmaceuticals (CTXR), with a price target of $4.00.
SmarterAnalyst · 6d ago
Thinking about buying stock in BlackBerry, Express, Norwegian Cruise Line, Citius Pharmaceuticals, or Verizon?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BB, EXPR, NCLH, CTXR, and VZ.
PR Newswire - PRF · 02/25 15:45
Dawson James Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR)
SmarterAnalyst · 02/25 09:07
3 Penny Stocks For Your Watch List This Week If Biotech Is A Focus
Feb 24, 2021 (Penny Stocks via COMTEX) -- Biotech Penny Stocks To Watch Right Now If one grouping of penny stocks that've gained attention in the markets, it...
Penny Stocks · 02/24 21:12
4 Cheap Penny Stocks To Buy For Under $5 Before March 2021
Feb 24, 2021 (Penny Stocks via COMTEX) -- Are These Cheap Penny Stocks On Your "Buy" List Today? When someone says the words "penny stocks," what comes to...
Penny Stocks · 02/24 21:12
Thinking about buying stock in Workhorse Group, Globalstar, Palantir Technologies, Marathon Oil, or Citius Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WKHS, GSAT, PLTR, MRO, and CTXR.
PR Newswire - PRF · 02/24 16:30
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CTXR. Analyze the recent business situations of Citius Pharmaceuticals Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CTXR stock price target is 6.00 with a high estimate of 8.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 35
Institutional Holdings: 2.08M
% Owned: 1.65%
Shares Outstanding: 125.79M
TypeInstitutionsShares
Increased
5
298.29K
New
17
464.54K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.94%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Chairman/Executive Director/Secretary
Leonard Mazur
President/Chief Executive Officer/Director
Myron Holubiak
Chief Financial Officer
Jaime Bartushak
Independent Director
Suren Dutia
Independent Director
Eugene Holuka
Independent Director
William Kane
Independent Director
Howard Safir
Independent Director
Carol Webb
No Data
  • All
  • Financials
  • Insiders
More
About CTXR
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is focused on developing and commercializing care products with a focus on anti-infective products in adjunct cancer care and prescription products. It has three product candidates: Mino-Lok, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (CRBSIs). Mino-Lok product is designed to salvage the central venous catheters CVC, obviating the need to remove and replace the catheter. Mino-Wrap is a bio-absorbable film impregnated with minocycline and rifampin for reducing acute inflammation and microbial colonization of breast tissue expanders used in breast reconstruction surgeries following mastectomies. CITI-002 is being developed for symptomatic relief of hemorrhoids. CITI-002 combines the steroid, halobetasol, with lidocaine.

Webull offers kinds of Citius Pharmaceuticals Inc stock information, including NASDAQ:CTXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTXR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CTXR stock methods without spending real money on the virtual paper trading platform.